Thomas Knogler
Overview
Explore the profile of Thomas Knogler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seebacher V, Rockall A, Nobbenhuis M, Sohaib S, Knogler T, Alvarez R, et al.
Arch Gynecol Obstet
. 2021 Nov;
305(5):1343-1352.
PMID: 34734326
Purpose: The aim of the present study is to investigate the prognostic significance of nutritional risk factors and sarcopenia on the outcome of patients with recurrent gynaecological malignancies treated by...
2.
Mucher P, Batmyagmar D, Perkmann T, Repl M, Radakovics A, Ponocny-Seliger E, et al.
Psychophysiology
. 2021 Mar;
58(5):e13799.
PMID: 33655551
In an aging society, late-life depression has become an increasing problem. There is evidence that physical activity ameliorates depressive symptoms and increases the quality of life (QoL). However, the underlying...
3.
Application of BI-RADS Descriptors in Contrast-Enhanced Dual-Energy Mammography: Comparison with MRI
Knogler T, Homolka P, Hoernig M, Leithner R, Langs G, Waitzbauer M, et al.
Breast Care (Basel)
. 2017 Oct;
12(4):212-216.
PMID: 29070983
Background: Contrast-enhanced (CE) magnetic resonance imaging (MRI) BI-RADS descriptors are used in the evaluation of contrast-enhanced dual-energy mammography (CEDEM) images of mass lesions and are assumed to be applicable. Patients...
4.
Aust S, Knogler T, Pils D, Obermayr E, Reinthaller A, Zahn L, et al.
PLoS One
. 2015 Oct;
10(10):e0140403.
PMID: 26457674
Objective: Tumor cachexia is an important prognostic parameter in epithelial ovarian cancer (EOC). Tumor cachexia is characterized by metabolic and inflammatory disturbances. These conditions might be reflected by body composition...
5.
Knogler T, Homolka P, Hornig M, Leithner R, Langs G, Waitzbauer M, et al.
Eur Radiol
. 2015 Sep;
26(6):1575-81.
PMID: 26373754
Objectives: To demonstrate the feasibility of contrast-enhanced dual-energy mammography (CEDEM) using titanium (Ti) filtering at 49 kVp for high-energy images and a novel artefact reducing image-subtraction post-processing algorithm. Methods: Fifteen...
6.
Knogler T, El-Rabadi K, Weber M, Karanikas G, Mayerhoefer M
Med Phys
. 2015 Aug;
42(8):4998.
PMID: 26233226
No abstract available.
7.
Mayerhoefer M, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, et al.
Clin Cancer Res
. 2015 Mar;
21(11):2506-13.
PMID: 25733598
Purpose: To determine the value of diffusion-weighted MRI (DWI-MRI) for treatment response assessment in 2-[18F]fluoro-2-deoxy-D-glucose (FDG)-avid lymphoma. Experimental Design: Patients with FDG-avid Hodgkin (HL) or non-Hodgkin lymphoma (NHL) at pretherapeutic...
8.
Knogler T, Thomas K, El-Rabadi K, Karem E, Weber M, Michael W, et al.
Med Phys
. 2014 Dec;
41(12):121904.
PMID: 25471964
Purpose: To determine the diagnostic performance of three-dimensional (3D) texture analysis (TA) of contrast-enhanced computed tomography (CE-CT) images for treatment response assessment in patients with Hodgkin lymphoma (HL), compared with...
9.
Leithner R, Knogler T, Homolka P
Phys Med Biol
. 2013 Jan;
58(3):N25-35.
PMID: 23322073
Phantoms containing iodine details with clinically relevant iodine concentrations are required to systematically study dose requirements, for quality assurance and optimizing exposure parameters and protocols for contrast enhanced dual energy...